Blood Loss and Transfusion Requirements in Metastatic Spinal Tumor Surgery: Evaluation of Influencing Factors

Annals of Surgical Oncology

Volumn 23, Issue 6, 2016, Pages 2079-2086

  Kumar, Naresh ^a   Zaw, Aye Sandar ^a   Khine, Hnin Ei ^a   Maharajan, Karthikeyan ^a   Wai, Khin Lay ^a   Tan, Barry ^a   Mastura, Siti ^a   Goy, Raymond ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID;

ADULT; ARTICLE; BLOOD TRANSFUSION; BREAST TUMOR; CANCER SURGERY; EPITHELIUM TUMOR; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; KIDNEY TUMOR; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; METASTATIC SPINAL TUMOR SURGERY; MYELOMA; OPERATION DURATION; OPERATIVE BLOOD LOSS; PRIMARY TUMOR; PROSTATE TUMOR; RETROSPECTIVE STUDY; SPINE METASTASIS; SPINE SURGERY; SPINE TUMOR; THYROID TUMOR; DECOMPRESSION SURGERY; FOLLOW UP; METASTASIS; MIDDLE AGED; MINIMALLY INVASIVE SURGERY; PROGNOSIS; SECONDARY; STATISTICS AND NUMERICAL DATA; UTILIZATION;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; DECOMPRESSION, SURGICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS;

EID: 84955585270     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-016-5092-8     Document Type: Article

References (33)

1. Chen Y, Tai BC, Nayak D, et al. Blood loss in spinal tumour surgery and surgery for metastatic spinal disease: a meta-analysis. Bone Jt J. 2013;95-B:683–8.
2. Holman PJ, Suki D, McCutcheon I, Wolinsky JP, Rhines LD, Gokaslan ZL. Surgical management of metastatic disease of the lumbar spine: experience with 139 patients. J Neurosurg Spine. 2005;2:550–63.
3. Xu R, Garces-Ambrossi GL, McGirt MJ, et al. Thoracic vertebrectomy and spinal reconstruction via anterior, posterior, or combined approaches: clinical outcomes in 91 consecutive patients with metastatic spinal tumors. J Neurosurg Spine. 2009;11:272–84.
4. Schmidt R, Rupp-Heim G, Dammann F, Ulrich C, Nothwang J. Surgical therapy of vertebral metastases: are there predictive parameters for intraoperative excessive blood loss despite preoperative embolization? Tumori. 2011;97:66–73.
5. Kouritas V, Graham S, Marwah G, Papastefanou SL. Can we reduce routine blood ordering in spinal surgery? Transfus Altern Transfus Med. 2010;11:138–42.
6. Kumar N, Zaw AS, Reyes MR, et al. Versatility of percutaneous pedicular screw fixation in metastatic spine tumor surgery: a prospective analysis. Ann Surg Oncol. 2015;22:1604–11.
7. Bilsky MH, Fraser JF. Complication avoidance in vertebral column spine tumors. Neurosurg Clin N Am. 2006;17:317–29-vii.
8. Hu SS. Blood loss in adult spinal surgery. Eur Spine J. 2004;13(Suppl 1):S3–5.
9. Jacobs WB, Perrin RG. Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus. 2001;11:e10.
10. Abe E, Kobayashi T, Murai H, Suzuki T, Chiba M, Okuyama K. Total spondylectomy for primary malignant, aggressive benign, and solitary metastatic bone tumors of the thoracolumbar spine. J Spinal Disord. 2001;14:237–46.
11. Chen YJ, Chang GC, Chen HT, et al. Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer. Spine Phila 1976. 2007;32:E413–8.
12. Cho DC, Sung JK. Palliative surgery for metastatic thoracic and lumbar tumors using posterolateral transpedicular approach with posterior instrumentation. Surg Neurol. 2009;71:424–33.
13. Street J, Fisher C, Sparkes J, et al. Single-stage posterolateral vertebrectomy for the management of metastatic disease of the thoracic and lumbar spine: a prospective study of an evolving surgical technique. J Spinal Disord Technol. 2007;20:509–20.
14. Tanaka M, Nakahara S, Ito Y, et al. Surgical treatment of metastatic vertebral tumors. Acta Med Okayama. 2009;63:145–50.
15. Olerud C, Jonsson H Jr, Lofberg AM, Lorelius LE, Sjostrom L. Embolization of spinal metastases reduces peroperative blood loss: 21 patients operated on for renal cell carcinoma. Acta Orthop Scand. 1993;64:9–12.
16. Berkefeld J, Scale D, Kirchner J, Heinrich T, Kollath J. Hypervascular spinal tumors: influence of the embolization technique on perioperative hemorrhage. AJNR Am J Neuroradiol. 1999;20:757–63.
17. Manke C, Bretschneider T, Lenhart M, et al. Spinal metastases from renal cell carcinoma: effect of preoperative particle embolization on intraoperative blood loss. AJNR Am J Neuroradiol. 2001;22:997–1003.
18. Deutsch H, Boco T, Lobel J. Minimally invasive transpedicular vertebrectomy for metastatic disease to the thoracic spine. J Spinal Disord Technol. 2008;21:101–5.
19. Scheufler KM. Technique and clinical results of minimally invasive reconstruction and stabilization of the thoracic and thoracolumbar spine with expandable cages and ventrolateral plate fixation. Neurosurgery. 2007;61:798–808 (Discussion 808–799).
20. Lau D, Chou D. Posterior thoracic corpectomy with cage reconstruction for metastatic spinal tumors: comparing the mini-open approach to the open approach. J Neurosurg Spine. 2015;23:217–27.
21. Alshryda S, Mason J, Sarda P, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Jt Surg Am. 2013;95:1969–74.
22. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Jt Surg Br Vol. 2011;93:39–46.
23. Badeaux J, Hawley D. A systematic review of the effectiveness of intravenous tranexamic acid administration in managing perioperative blood loss in patients undergoing spine surgery. J Perianesthes Nurs. 2014;29:459–65.
24. Zhang F, Wang K, Li FN, et al. Effectiveness of tranexamic acid in reducing blood loss in spinal surgery: a meta-analysis. BMC Musculoskelet Disord. 2014;15:448.
25. Clausen C, Dahl B, Frevert SC, Hansen LV, Nielsen MB, Lonn L. Preoperative embolization in surgical treatment of spinal metastases: single-blind, randomized controlled clinical trial of efficacy in decreasing intraoperative blood loss. JVIR J Vasc Interv Radiol. 2015;26:402–12; e401.
26. Kawai A, Kadota H, Yamaguchi U, Morimoto Y, Ozaki T, Beppu Y. Blood loss and transfusion associated with musculoskeletal tumor surgery. J Surg Oncol. 2005;92:52–8.
27. Blajchman MA, Bordin JO. The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Investig. 1995;24:311–7.
28. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol. 1997;34(3 Suppl 2):34–40.
29. Kumar N, Ahmed Q, Lee VK, et al. Can there be a place for intraoperative salvaged blood in spine tumor surgery? Ann Surg Oncol. 2014;21:2436–43.
30. Kumar N, Ahmed Q, Lee VK, Zaw AS, Goy R, Wong HK. Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery? Eur Spine J. 2015. doi:10.1007/s00586-015-4112-x.
31. Kumar N, Chen Y, Nath C, Liu EH. What is the role of autologous blood transfusion in major spine surgery? Am J Orthop Belle Mead NJ 2012;41:E89–95.
32. Kumar N, Chen Y, Zaw AS, et al. Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. Lancet Oncol 2014;15:e33–41.
33. Kumar N, Lam R, Zaw AS, et al. Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery. Ann Surg Oncol. 2014;21:4330–5.